BMS-1(HY19991), cas: 1675201-83-8,PD-L11,(S)-1-(2,6-二甲氧基-4-((2-甲基-[1,1'-联苯]-3-基)甲氧基)苄基)哌啶-2-甲酸
BMS-1(HY19991), cas: 1675201-83-8 ,PD-L1**剂1,(S)-1-(2,6-二甲氧基-4-((2-甲基-[1,1'-联苯]-3-基)甲氧基)苄基)哌啶-2-甲酸
英文姓字名字:PD-1中文名字同义词:(S)-1-(2,6-二甲氧基-4-((2-甲基-[1,1'-联苯]-3-基)甲氧基)苄基)哌啶-2-甲酸(2S)-1-[[2,6-二甲氧基-4-[(2-甲基[1,1'-联苯]-3-基)甲氧基]苯基]甲基]-2-哌啶羧酸PD-L1**剂1有机化合物PD-1/PD-L1INHIBITOR1日语明称:2-Piperidinecarboxylicacid,1-[[2,6-dimethoxy-4-[(2-methyl[1,1'-biphenyl]-3-yl)methoxy]phenyl]methyl]-,(2S)-英文音标同义词:T3655;(2S)-1-{2,6-Dimethoxy-4-[(2-methyl-3-biphenylyl)methoxy]benzyl}-2-piperid**inecarboxylicacid2-Piperidinecarboxylicacid,1-[[2,6-dimethoxy-4-[(2-methyl[1,1'-biphenyl]-3-yl)methoxy]phenyl]methyl]-,(2S)-PD1-PDL1inhibitor1PD-1PD-L1inhibitor(2S)-1-[[2,6-Dimethoxy-4-[(2-methyl[1,1'-biphenyl]-3-yl)methoxy]phenyl]methyl]-2-piperidinecarboxylicacid;avelumab/PD-L1PD1-PDL1inhibitor1(PD1-PDL1-IN1)CAS号:1675201-83-8
分子结构式:C29H33NO5分子结构量:475.58熔点 630.2±55.0 °C(Predicted)容重 1.182±0.06 g/cm3(Predicted)酸度常数(pKa)2.34±0.20(Predicted)BMS-1(HY19991), cas: 1675201-83-8 ,PD-L1**剂1的生物活性
BMS-1 (PD-1/PD-L1 inhibitor 1, PD1-PDL1-IN1)一种PD-1/PD-L1相护用处的小原子有机化合物**剂,IC50为6 nM。BMS-1(HY19991), cas: 1675201-83-8 ,PD-L1**剂1的结构式
DSPC,cas816-94-4 | 1g |
DSPE | 10g |
DSPE-HYD-mPEG, MW:2000 | 100mg |
DSPE-HYD-PEG2K | 500mg |
DSPE-Hyd-PEG2K-cRGD | 20mg |
DSPE-Hyd-PEG2K-FITC | 50mg |
DSPE-MAL | 500mg |
DSPE-mPEG2000 | 1g |
DSPE-mPEG2000 | 1g |
DSPE-mPEG2K | 100MG |
DSPE-mPEG5000 | 5g |
DSPE-NHS | 500mg |
温馨提示:仅用于科研,不能用于人体实验!